Primed Avian Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Restore Granulosa Cell Homeostasis in a CTX-Induced POI-like Dysfunction Model Under Human Menopausal Gonadotropin Stimulation.
Primed AMSC-sEVs appear to restore granulosa cell function more effectively than hMG alone in a CTX-induced dysfunction model, but the implications for clinical practice are unclear.
Where it sits
this study against the rest of the hmg (human menopausal gonadotropin) corpusSummary and findings
This study evaluated the effects of primed avian mesenchymal stem cell-derived small extracellular vesicles (primed AMSC-sEVs) on granulosa cell homeostasis in a cyclophosphamide (CTX)-induced POI-like dysfunction model under human menopausal gonadotropin (hMG) stimulation. The study found that CTX reduced several functional markers in granulosa cells, while primed AMSC-sEVs restored these markers more effectively than naïve AMSC-sEVs. No therapeutic claims are made regarding the use of hMG or AMSC-sEVs.
Abstract
Premature ovarian insufficiency (POI) is a heterogeneous disorder, and cyclophosphamide (CTX)-induced ovarian injury represents an acquired POI-like condition rather than the full clinical spectrum of POI. In this study, CTX was used to establish a granulosa cell dysfunction model to evaluate whether primed avian mesenchymal stem cell-derived small extracellular vesicles (primed AMSC-sEVs) could restore granulosa cell homeostasis under human menopausal gonadotropin (hMG) stimulation, a clinically relevant gonadotropin context used in ovarian stimulation. Human granulosa cells were exposed to CTX and subsequently treated with hMG, naïve AMSC-sEVs, or primed AMSC-sEVs. Cell viability, mitochondrial membrane potential, <i>AMH</i> and <i>FSHR</i> expression, and hormone secretion were examined. CTX reduced cell viability, mitochondrial membrane potential, <i>AMH</i> and <i>FSHR</i> expression, and AMH/estradiol secretion, confirming the establishment of a POI-like granulosa cell dysfunction state. hMG partially restored selected functional markers but showed limited effects on cell viability and mitochondrial recovery. In contrast, primed AMSC-sEVs markedly restored granulosa cell viability, mitochondrial membrane potential, AMH and FSHR expression, and endocrine output, with stronger effects than naïve AMSC-sEVs. Co-treatment with hMG did not consistently enhance the restorative effects of primed AMSC-sEVs beyond those achieved by primed AMSC-sEVs alone. These findings indicate that primed AMSC-sEVs primarily act by restoring granulosa cell and mitochondrial homeostasis, thereby supporting the cellular competence required for gonadotropin responsiveness in an acquired POI-like condition.
Background
The paper addresses the restoration of granulosa cell homeostasis in the context of chemotherapy-induced premature ovarian insufficiency (POI). Previous studies have suggested that extracellular vesicles may play a role in cellular communication and recovery in ovarian dysfunction. This study is significant as it explores the potential of HMG in conjunction with stem cell-derived vesicles to mitigate the effects of POI.
Methods
The study design and specific methodologies are not detailed in the abstract. The population or model used, sample size (n), dosing regimen, duration, and the primary versus secondary outcome measures are also not reported.
Results
The results section does not provide specific numeric findings or outcomes in the abstract. Therefore, the primary endpoint and any associated statistics such as effect size, p-value, or confidence intervals are not available.
Interpretation
Without specific results, it is difficult to compare the findings to prior literature or assess the clinical significance of any observed effects. The lack of reported data limits the ability to draw conclusions about the implications for practice or the potential confounding factors that may affect the results.
Key findings
- Not reported in abstract.
Limitations
- Not reported in abstract.